Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/03/2010US20100136126 Composition and microsphere for controlled-release of exendin, and method of preparing the same
06/03/2010US20100136125 Method of treating inflammatory bowel disease
06/03/2010US20100136124 Nanoparticle-coated capsule formulation for dermal drug delivery
06/03/2010US20100136123 Microcapsule Sheet
06/03/2010US20100136122 Oral Preparation Comprising Pioglitazone
06/03/2010US20100136121 Medicaments
06/03/2010US20100136120 Compositions and methods for forming and strengthening bone
06/03/2010US20100136119 Controlled-release preparation containing cilostazol and process for the preparation thereof
06/03/2010US20100136118 Calcium absorption enhancer
06/03/2010US20100136117 Hydroxyapatite tissue filler and its preparation and use
06/03/2010US20100136116 Novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
06/03/2010US20100136115 Pharmaceutical Titanium Dioxide Composite Allowing Disappearance of Drug Efficacy By Light Irradiation
06/03/2010US20100136114 De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progentitor cells
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136111 Pharmaceutical compositions of diclofenac and misoprostol
06/03/2010US20100136110 Granular pharmaceutical composition for oral administration
06/03/2010US20100136109 Sustained release
06/03/2010US20100136108 Formulation for retinoid-containing soft gelatin capsules
06/03/2010US20100136107 Liquid Therapeutic Composition
06/03/2010US20100136106 Modified Release Famciclovir Compositions
06/03/2010US20100136105 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100136104 Nutritional supplement for use under physiologically stressful conditions
06/03/2010US20100136103 Cosmetic anti-ageing skin care compositions
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136099 Liposome for induction of cell-mediated immunity
06/03/2010US20100136098 Avian influenza vaccine
06/03/2010US20100136097 Systems for modulating inflammation
06/03/2010US20100136096 Systems for modulating inflammation
06/03/2010US20100136095 Systems for modulating inflammation
06/03/2010US20100136094 Systems for modulating inflammation
06/03/2010US20100136093 Immunotherapeutic Method For Increasing Groundnut Tolerance In A Subject
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136091 Methods, systems, and compositions for extracellular matrix production
06/03/2010US20100136089 Location of fatty acid esters on tampons and toxin inhibiting efficacy
06/03/2010US20100136088 Magnetizable tampon device
06/03/2010US20100136085 Compositions and methods for arthrodetic procedures
06/03/2010US20100136083 Metal Implants
06/03/2010US20100136080 Material depot for releasing an antibacterial active agent
06/03/2010US20100136066 Novel Inverse Latex Of Anionic Polyelectrolytes In Silicones Oils; Cosmetic Use
06/03/2010US20100136064 Nutraceutical composition
06/03/2010US20100136063 Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides
06/03/2010US20100136062 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
06/03/2010US20100136043 Composition comprising immunogenic microparticles
06/03/2010US20100135982 Simethicone solid oral dosage form
06/03/2010US20100135916 Water in silicone emulsions containing elastomers
06/03/2010US20100135915 Foam material for medical use and method for producing same
06/03/2010US20100135908 Delivery devices for modulating inflammation
06/03/2010CA2750421A1 Surface active proteins as excipients in solid pharmaceutical formulations
06/03/2010CA2748344A1 Enhanced bioactive formulations of resveratrol
06/03/2010CA2746205A1 Dosage form for insertion into the mouth
06/03/2010CA2744909A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010CA2744861A1 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine
06/03/2010CA2744655A1 Novel powdered crystalline medicines for inhalation
06/03/2010CA2744587A1 Compositions with reduced dimer formation
06/03/2010CA2744515A1 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
06/03/2010CA2743824A1 Implantable ocular drug delivery device and methods
06/03/2010CA2743427A1 Antioxidant compositions for soft oral tissue and methods of formulation and use thereof
06/03/2010CA2743243A1 Solution of lipophilic substances, especially medicinal solutions
06/03/2010CA2742645A1 Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
06/03/2010CA2742621A1 Plant extract compositions for affecting sleep
06/03/2010CA2741751A1 Extended release oral acetaminophen/tramadol dosage form
06/03/2010CA2740865A1 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient
06/02/2010EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation
06/02/2010EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I
06/02/2010EP2191890A1 Process for producing fine particles and the fine particles
06/02/2010EP2191848A1 Sustained release preparation and process for production thereof
06/02/2010EP2191839A2 Immunogenic LHRH compositions and methods relating thereto
06/02/2010EP2191833A1 Transdermally absorbable preparation
06/02/2010EP2191830A1 Solid preparation comprising npyy5 receptor antagonist
06/02/2010EP2191828A1 Antifungal pharmaceutical composition
06/02/2010EP2191827A1 Antifungal composition
06/02/2010EP2191826A1 Pharmaceutical composition
06/02/2010EP2191824A1 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
06/02/2010EP2191822A1 Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine
06/02/2010EP2191821A1 Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
06/02/2010EP2191820A1 Pharmaceutical formulations of meloxicam
06/02/2010EP2191810A1 Cosmetic auxiliary patch material and method of cosmetizing therewith
06/02/2010EP2190974A1 Apparatus and method for dehydrating biological materials
06/02/2010EP2190467A1 Materials and methods for treating or preventing organophosphate exposure associated damage
06/02/2010EP2190439A2 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
06/02/2010EP2190436A2 Sulfasalazine formulations in a biodegradable polymer carrier
06/02/2010EP2190420A1 Gelatin-based coatings having improved durability
06/02/2010EP2190419A1 Multi particulate matrix system containing galantamine
06/02/2010EP2190418A1 Immediate release and sustained release ibuprofen dosing regiment
06/02/2010EP2190416A1 Method and composition for making an orally disintegrating dosage form
06/02/2010EP2190415A2 Pharmaceutical compositions of fenofibrate
06/02/2010EP2190412A2 Liposome formulations of boronic acid compounds
06/02/2010EP2190411A2 Liposome compositions for in vivo administration of boronic acid compounds
06/02/2010EP2190410A2 Use of carbon nanotube for drug delivery
06/02/2010EP2190409A1 Delivery of drug combinations
06/02/2010EP2190408A2 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
06/02/2010EP2190392A1 Transdermal drug delivery systems comprising a coated release liner
06/02/2010EP1466914B1 Amorphous substance of tricyclic triazolobenzazepine derivative
06/02/2010EP1334732B1 Pharmaceutical preparation of n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4 b]furan-8-yl)ethyl]propionamide coated with a copolyvidone-containing coating free of polyethylene glycol
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010DE112008001179T5 Mittel für die Behandlung und zur Vorsorge von gutartiger Prostatahyperplasie, Prostatitis, Impotenz, Unfruchtbarkeit und Prostatakarzinom und das Verfahren seiner Anwendung Agents for the treatment and prevention of benign prostatic hyperplasia, prostatitis, impotence, infertility, and prostate cancer, and the method of its application
06/02/2010CN201492711U Cordyceps sinensis tablet
06/02/2010CN201492710U Immunity regulation preparation structure
06/02/2010CN1994457B Swelling-relieving pain-stopping externally applied ointment
1 ... 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 ... 2991